Company intelligence / Profile preview

Sudoscan

Issy les Moulineaux / Paris area, Francesudoscan.com ↗

Ownership: Private
Development stage: Commercial

Overview

Sudoscan, formerly known as Impeto Medical, has developed and commercialized a non-invasive medical device for the early detection and monitoring of autonomic and small fiber neuropathies. Its flagship product, SUDOSCAN, is FDA-cleared and CE-marked for use in multiple indications including diabetes, neurology, oncology, and rare diseases. The technology is now being integrated into Withings' connected health devices following its acquisition in 2022.

Therapeutic areas: EndocrinologyNeurology
Modalities: DeviceNon-pharmacological therapy (diagnostic/monitoring)
Industry: Physiological Monitoring

Partnerships

Withings (acquirer/integrator)

Beyond the preview

Go deeper on Sudoscan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sudoscan.

Explore the full profile